The Prognostic Values of GDF-15 in Comparison with NT-proBNP in Patients with Normotensive Acute Pulmonary Embolism

Duran L., Kayhan S., Guzel A., Ince M., Katı C., Akdemir H. U., ...More

CLINICAL LABORATORY, vol.60, no.8, pp.1365-1371, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 60 Issue: 8
  • Publication Date: 2014
  • Doi Number: 10.7754/clin.lab.2013.130827
  • Journal Name: CLINICAL LABORATORY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1365-1371
  • Keywords: pulmonary embolism, thrombosis, vascular disease, venous thromboembolism, GROWTH-DIFFERENTIATION FACTOR-15, BRAIN NATRIURETIC PEPTIDE, MACROPHAGE INHIBITORY CYTOKINE-1, RISK STRATIFICATION, SEVERITY INDEX, HEART-FAILURE, MANAGEMENT, DIAGNOSIS, MODEL
  • Ondokuz Mayıs University Affiliated: Yes

Abstract

Background: An early prediction of prognosis in pulmonary embolism (PE) is a crucial clinical entity. The aim of the study is to investigate whether growth differentiation factor-15 (GDF-15) or N-terminal pro-brain natriuretic peptide levels (NT-proBNP) can better predict the 30 day overall mortality in patients with normotensive acute PE.